Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

Vonoprazan on the Eradication of Helicobacter pylori Infection
CONCLUSION: Both vonoprazan triple therapy and vonoprazan quadruple therapy regimens could increase the eradication rate of H. pylori. Vonoprazan triple therapy exhibited reduced side effects and could be applied in the eradication of H. pylori in the clinic.PMID:36511603 | DOI:10.5152/tjg.2022.211041 (Source: The Turkish Journal of Gastroenterology)
Source: The Turkish Journal of Gastroenterology - December 13, 2022 Category: Gastroenterology Authors: Jiaming Huang Ye Lin Source Type: research

High Pseudocapacitance ‐Driven CoC2O4 Electrodes Exhibiting Superior Electrochemical Kinetics and Reversible Capacities for Lithium‐Ion and Lithium–Sulfur Batteries
In this study, cuboid-like anhydrous CoC2O4 particles (CoC2O4-HK) are synthesized through a potassium citrate-assisted hydrothermal method, which possess well-crystallized structure for fast Li+ transportation and efficient Li+ intercalation pseudocapacitive behaviors. When being used in lithium-ion batteries, the as-prepared CoC2O4-HK delivers a high reversible capacity ( ≈1360 mAh g-1 at 0.1 A g-1), good rate capability ( ≈650 mAh g-1 at 5 A g-1) and outstanding cycling stability (835 mAh g-1 after 1000 cycles at 1 A g-1). Characterizations illustrate that the Li+-intercalation pseudocapacitance dominates the charge ...
Source: Small - November 8, 2022 Category: Nanotechnology Authors: Zhiming Zhou, Peirong Lin, Shiqiang Zhao, Huile Jin, Yudan Qian, Xi,an Chen, Xinyue Tang, Qingcheng Zhang, Daying Guo, Shun Wang Tags: Research Article Source Type: research

Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial
CONCLUSIONS: Fourteen-day HDDT is non-inferior to bismuth-containing quadruple therapy, with fewer adverse effects and good treatment compliance, suggesting HDDT as an alternative for H. pylori rescue treatment in the local region.TRIAL REGISTRATION: Clinicaltrials.gov, NCT04678492.PMID:36193978 | DOI:10.1097/CM9.0000000000002289 (Source: Chinese Medical Journal)
Source: Chinese Medical Journal - October 4, 2022 Category: General Medicine Authors: Hanxin Bi Xingxing Chen Yuxin Chen Xin Zhao Shasha Wang Jiehong Wang Ting Lyu Shuang Han Tao Lin Mingquan Li Donghong Yuan Junye Liu Yongquan Shi Source Type: research

Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial
CONCLUSIONS: Fourteen-day HDDT is non-inferior to bismuth-containing quadruple therapy, with fewer adverse effects and good treatment compliance, suggesting HDDT as an alternative for H. pylori rescue treatment in the local region.TRIAL REGISTRATION: Clinicaltrials.gov, NCT04678492.PMID:36193978 | DOI:10.1097/CM9.0000000000002289 (Source: Chinese Medical Journal)
Source: Chinese Medical Journal - October 4, 2022 Category: General Medicine Authors: Hanxin Bi Xingxing Chen Yuxin Chen Xin Zhao Shasha Wang Jiehong Wang Ting Lyu Shuang Han Tao Lin Mingquan Li Donghong Yuan Junye Liu Yongquan Shi Source Type: research

Editorial Comment
In 1985, potassium citrate was approved by the FDA for kidney stone prevention in distal renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate nephrolithiasis of any etiology and uric acid lithiasis with or without calcium stones. Potassium citrate is now widely used either alone or in combination with thiazide or thiazide analogue diuretics for the treatment of calcium nephrolithiasis. (Source: Urology)
Source: Urology - October 1, 2022 Category: Urology & Nephrology Authors: Sakhaee Khashayar Source Type: research